Róbert Wessman has announced that he will step down from his position as CEO of the Icelandic pharmaceutical company Actavis Group after ten years of leading the company and will be replaced by Sigurdur Óli Ólafsson, Actavis’ current deputy CEO.
According to Morgunbladid, Wessman will now focus on his investment company Salt Investment, but will continue to have a seat on the board of Actavis.
Actavis’ owners apparently felt that Wessman’s interests in Salt Investment might draw his attention away from Actavis’ daily operations.
Wessman said he had discussed it with the chairman of Actavis’ board Björgólfur Thor Björgólfsson a few times that it was time for him to quit as CEO.
